According to a new report from the American Association for Cancer Research, there are more cancer survivors in the United States than ever before.
Over the past three years, the number of cancer survivors in the US—defined as survivors who have been diagnosed with cancer—has increased by more than a million. The association said there are 18 million survivors in the US as of January, with that number expected to rise to 26 million by 2040. The report states that only 3 million US . Were Survived cancer in 1971.
For all cancers combined, the five-year overall survival rate has increased from 49% in the mid-1970s to nearly 70% from 2011 to 2017, the most recent years for which data are available.
The association said the age-adjusted total cancer mortality rate continues to decline, with a decrease between 1991 and 2019 that nearly 3.5 million deaths were avoided.
Declines in smoking and improvements in detecting and treating cancer early are driving change, according to AACR Cancer Progress Report 2022Released on Wednesday.
Association President Dr. Lisa Cousens said in a Statement Part of that credit goes to investment in research – for treatment and understanding the disease.
“Targeted therapy, immunotherapy, and other new therapeutic approaches being applied clinically all stem from fundamental discoveries in basic science,” she said. “Investment in oncology, as well as support for science education at all levels, is absolutely essential to drive the next wave of discoveries and accelerate progress.”
For example, between August 1 and July 31, the US Food and Drug Administration approved eight anticancer therapeutics, expanded the use of 10 drugs already approved to treat new cancer types, and approved two diagnostic imaging agents. Granted, Cousens said at a news conference on Wednesday.
Increased funding for cancer research is a cornerstone of President Joe Biden’s revamped Cancer Moonshot initiative.
“Cancer doesn’t discriminate between red and blue. It doesn’t matter whether you’re a Republican or a Democrat. Defeating cancer is something we can do together,” said Biden, who initially served as Obama’s vice president. Taking the initiative.
New report urges Congress to fully fund and support Biden’s goalend cancer as we know it,
“The governance of cancer moonshot will provide an important framework for improving cancer prevention strategies; increasing cancer screening and early detection; reducing cancer disparities; and leading to new lifesaving therapies for cancer patients.” “The actions will transform cancer care, increase survival, and bring life-saving treatment to the millions of people whose lives are touched by cancer,” the report says.
Although approximately 3.5 million cancer deaths were avoided between 1991 and 2019, according to the association, more than 600,000 people are still expected to die from cancer in the US.
“In the United States alone, the number of new cancer cases diagnosed each year is expected to reach approximately 2.3 million by 2040,” the report said.
According to the report, about 40% of cancer cases in the US are due to risk factors such as smoking, drinking too much alcohol, eating a poor diet, not getting enough exercise, and being obese.
But there are also challenges such as health disparities that affect racial and ethnic minorities and barriers to health care such as limited health insurance coverage and living in rural areas.
In a recorded statement played at the news conference, US Representative Nikema Williams said she learned after her mother’s death from cancer that “health care in America is not yet a human right.”
“We have two health care systems in this country: one for people who can afford preventive services and quality treatment, and one for everyone else,” said Williams, a Democrat from Georgia.
The report states that Roe v. Wade’s reversal is also expected to affect cancer care by limiting health care options for pregnant women with cancer.
“With the recent Supreme Court ruling overturning Roe v. Wade, which nullifies the constitutional right to abortion, there is uncertainty about how a particular cancer treatment can lead to termination of pregnancy. As such The uncertainty of the drug may prevent some physicians from prescribing medication or performing other health services in a timely manner due to potential legal consequences for both the physician and the mother,” according to the report.
The COVID-19 pandemic has had an impact on cancer in the US, with nearly 10 million breast, colorectal and prostate cancer screenings missed in 2020.
The report provides recommendations for building on progress and getting up to speed.
“Making progress to eliminate cancer means more birthdays, more Christmas, more graduations and everyday moments for families everywhere,” Williams said.